167 related articles for article (PubMed ID: 9627656)
21. Relationship between macular microcirculation and progression of diabetic macular edema.
Sakata K; Funatsu H; Harino S; Noma H; Hori S
Ophthalmology; 2006 Aug; 113(8):1385-91. PubMed ID: 16877077
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of volumetric measurements of normal maculae with the Heidelberg retina tomograph.
Zambarakji HJ; Evans JE; Amoaku WM; Vernon SA
Br J Ophthalmol; 1998 Aug; 82(8):884-91. PubMed ID: 9828771
[TBL] [Abstract][Full Text] [Related]
24. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW
Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533
[TBL] [Abstract][Full Text] [Related]
25. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
26. Web-based grading of compressed stereoscopic digital photography versus standard slide film photography for the diagnosis of diabetic retinopathy.
Rudnisky CJ; Tennant MT; Weis E; Ting A; Hinz BJ; Greve MD
Ophthalmology; 2007 Sep; 114(9):1748-54. PubMed ID: 17368543
[TBL] [Abstract][Full Text] [Related]
27. Topography of diabetic macular edema with optical coherence tomography.
Hee MR; Puliafito CA; Duker JS; Reichel E; Coker JG; Wilkins JR; Schuman JS; Swanson EA; Fujimoto JG
Ophthalmology; 1998 Feb; 105(2):360-70. PubMed ID: 9479300
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
29. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
Kim SJ; Equi R; Bressler NM
Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema.
Gaucher D; Tadayoni R; Erginay A; Haouchine B; Gaudric A; Massin P
Am J Ophthalmol; 2005 May; 139(5):807-13. PubMed ID: 15860284
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
32. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
Burkholder BM; Osborne B; Loguidice MJ; Bisker E; Frohman TC; Conger A; Ratchford JN; Warner C; Markowitz CE; Jacobs DA; Galetta SL; Cutter GR; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
Arch Neurol; 2009 Nov; 66(11):1366-72. PubMed ID: 19901168
[TBL] [Abstract][Full Text] [Related]
33. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
Gupta A; Gupta V; Thapar S; Bhansali A
Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of retinal thickness in macular region in diabetic patients with RTA analyzer].
Polaczek-Krupa B; Grabska-Liberek I; Terelak-Borys B
Klin Oczna; 2009; 111(4-6):119-21. PubMed ID: 19673438
[TBL] [Abstract][Full Text] [Related]
35. Scanning laser edema index: a reliable tool to correlate with diabetic retinopathy and systemic risk factors?
Peyman M; Tajunisah I; Loo A; Chuah KC; Subrayan V
J Diabetes Complications; 2012; 26(3):210-3. PubMed ID: 22520399
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
37. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus.
Escaravage GK; Cohen KL; Patel SB; Hartnett ME; Armstrong BD; Janowski CM
J Cataract Refract Surg; 2006 May; 32(5):803-11. PubMed ID: 16765799
[TBL] [Abstract][Full Text] [Related]
38. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
39. Improvement of reproducibility of macular volume measurements using the Heidelberg retinal tomograph.
Ang A; Tong L; Vernon SA
Br J Ophthalmol; 2000 Oct; 84(10):1194-7. PubMed ID: 11004110
[TBL] [Abstract][Full Text] [Related]
40. Overnight thickness variation in diabetic macular edema.
Larsen M; Wang M; Sander B
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2313-6. PubMed ID: 15980216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
